GB201016912D0 - Novel combination - Google Patents

Novel combination

Info

Publication number
GB201016912D0
GB201016912D0 GBGB1016912.6A GB201016912A GB201016912D0 GB 201016912 D0 GB201016912 D0 GB 201016912D0 GB 201016912 A GB201016912 A GB 201016912A GB 201016912 D0 GB201016912 D0 GB 201016912D0
Authority
GB
United Kingdom
Prior art keywords
novel combination
novel
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1016912.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GBGB1016912.6A priority Critical patent/GB201016912D0/en
Publication of GB201016912D0 publication Critical patent/GB201016912D0/en
Application status is Ceased legal-status Critical

Links

GBGB1016912.6A 2010-10-07 2010-10-07 Novel combination Ceased GB201016912D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB1016912.6A GB201016912D0 (en) 2010-10-07 2010-10-07 Novel combination

Applications Claiming Priority (14)

Application Number Priority Date Filing Date Title
GBGB1016912.6A GB201016912D0 (en) 2010-10-07 2010-10-07 Novel combination
BR112013008362A BR112013008362A2 (en) 2010-10-07 2011-10-05 combinations
MX2013003816A MX2013003816A (en) 2010-10-07 2011-10-05 Novel combinations.
EP11781829.4A EP2624838A1 (en) 2010-10-07 2011-10-05 Novel combinations
PCT/GB2011/051898 WO2012046050A1 (en) 2010-10-07 2011-10-05 Novel combinations
KR1020137008725A KR20130126595A (en) 2010-10-07 2011-10-05 Novel combinations
CA 2813684 CA2813684A1 (en) 2010-10-07 2011-10-05 Novel combinations
JP2013532266A JP2013538867A (en) 2010-10-07 2011-10-05 Novel combination
RU2013115103/15A RU2013115103A (en) 2010-10-07 2011-10-05 new combinations
AU2011311310A AU2011311310A1 (en) 2010-10-07 2011-10-05 Novel combinations
SG2013019666A SG188575A1 (en) 2010-10-07 2011-10-05 Novel combinations
CN 201180058933 CN103249418A (en) 2010-10-07 2011-10-05 Novel combinations
IL225312A IL225312D0 (en) 2010-10-07 2013-03-18 Novel combinations
IN567/MUMNP/2013A IN2013MN00567A (en) 2010-10-07 2013-03-22 Novel combinations

Publications (1)

Publication Number Publication Date
GB201016912D0 true GB201016912D0 (en) 2010-11-24

Family

ID=43304217

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1016912.6A Ceased GB201016912D0 (en) 2010-10-07 2010-10-07 Novel combination

Country Status (14)

Country Link
EP (1) EP2624838A1 (en)
JP (1) JP2013538867A (en)
KR (1) KR20130126595A (en)
CN (1) CN103249418A (en)
AU (1) AU2011311310A1 (en)
BR (1) BR112013008362A2 (en)
CA (1) CA2813684A1 (en)
GB (1) GB201016912D0 (en)
IL (1) IL225312D0 (en)
IN (1) IN2013MN00567A (en)
MX (1) MX2013003816A (en)
RU (1) RU2013115103A (en)
SG (1) SG188575A1 (en)
WO (1) WO2012046050A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150027922A (en) * 2013-09-04 2015-03-13 주식회사 대웅제약 Novel antifungal pyridinylhydrazide derivatives
KR101657678B1 (en) * 2013-11-05 2016-09-20 주식회사 대웅제약 Novel compound, method for preparation thereof, and antifungal composition comprising the same
WO2018059537A1 (en) * 2016-09-30 2018-04-05 四川海思科制药有限公司 Diazaspiro[5.5]undecane derivative and use thereof

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8334494D0 (en) 1983-12-24 1984-02-01 Tanabe Seiyaku Co Carbostyril derivatives
ES2165768B1 (en) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa New quinuclidine derivatives and pharmaceutical compositions containing them.
GB0003154D0 (en) 2000-02-12 2000-04-05 Astrazeneca Uk Ltd Novel compounds
GB0103630D0 (en) 2001-02-14 2001-03-28 Glaxo Group Ltd Chemical compounds
AT381537T (en) 2001-03-22 2008-01-15 Glaxo Group Ltd Formanilide-derivative as beta2-adrenergic agonists
SE0102616D0 (en) 2001-07-25 2001-07-25 Astrazeneca Ab Novel compounds
SE0102617D0 (en) 2001-07-25 2001-07-25 Astrazeneca Ab Novel compounds
PT1425001E (en) 2001-09-14 2009-02-18 Glaxo Group Ltd Phenethanolamine derivatives for treatment of respiratory diseases
TWI249515B (en) 2001-11-13 2006-02-21 Theravance Inc Aryl aniline beta2 adrenergic receptor agonists
TW200409746A (en) 2002-07-26 2004-06-16 Theravance Inc Crystalline β2 adrenergic receptor agonist
DE60320439T2 (en) 2002-10-11 2009-05-20 Pfizer Inc. Indole derivatives ALS ß2 AGONISTS
KR20050057681A (en) 2002-10-28 2005-06-16 글락소 그룹 리미티드 Phenethanolamine derivative for the treatment of respiratory diseases
SE0300091D0 (en) 2003-01-15 2003-01-15 Astrazeneca Ab Novel compounds
SE0300092D0 (en) 2003-01-15 2003-01-15 Astrazeneca Ab Novel compounds
PE09502004A1 (en) 2003-02-14 2005-01-01 Theravance Inc Biphenyl derivatives as agonists beta2 adrenoceptor antagonists RECEIVERS AND muscarinic receptor
JP4767842B2 (en) 2003-04-01 2011-09-07 セラヴァンス, インコーポレーテッド Diarylmethyl compounds and related compounds having a β2 adrenergic receptor agonist activity and muscarinic receptor antagonist activity
US7358244B2 (en) 2003-05-28 2008-04-15 Theravance, Inc. Azabicycloalkane compounds
WO2006066907A1 (en) 2004-12-21 2006-06-29 Glaxo Group Limited Pharmaceutical formulations
TW200526547A (en) 2003-09-22 2005-08-16 Theravance Inc Amino-substituted ethylamino β2 adrenergic receptor agonists
US7345060B2 (en) 2003-11-21 2008-03-18 Theravance, Inc. Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity
GB0402797D0 (en) 2004-02-09 2004-03-10 Novartis Ag Organic compounds
US7745621B2 (en) 2004-05-14 2010-06-29 Boehringer Ingelheim International Gmbh Long acting bronchodilators for the treatment of respiratory diseases
DE102004024453A1 (en) 2004-05-14 2006-01-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg New long-acting bronchodilators for the treatment of respiratory diseases
EP1751086A2 (en) 2004-06-03 2007-02-14 Theravance, Inc. DIAMINE ß2 ADRENERGIC RECEPTOR AGONISTS
US20060002967A1 (en) 2004-07-01 2006-01-05 Smestad Thomas L Resorbable implant with lubricious coating
JP2008510014A (en) 2004-08-16 2008-04-03 セラヴァンス, インコーポレーテッド Compounds having a β2 adrenergic receptor agonist activity and muscarinic receptor antagonist activity
EP1833822A2 (en) 2004-08-16 2007-09-19 Theravance, Inc. Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
GB0425057D0 (en) 2004-11-12 2004-12-15 Pfizer Ltd L-tartrate salt of N-1-adamantyl-2-{3-[(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]eth yl}amino)propyl]phenyl}acetamide
US20060114254A1 (en) 2004-11-26 2006-06-01 Tim Day Volume rendering apparatus and method
ES2265276B1 (en) 2005-05-20 2008-02-01 Laboratorios Almirall S.A. Derivatives of 4- (2-amino-1-hydroxyethyl) phenol as beta2 adrenergic receptor agonists.
GB0512246D0 (en) 2005-06-15 2005-07-27 Glaxo Group Ltd Novel pharmaceutical
MEP9608A (en) 2006-03-20 2010-06-10 Pfizer Ltd Amine derivatives
ES2296516B1 (en) 2006-04-27 2009-04-01 Laboratorios Almirall S.A. Derivatives of 4- (2-amino-1-hydroxyethyl) phenol as beta2 adrenergic receptor agonists.
TW200808771A (en) 2006-05-08 2008-02-16 Astrazeneca Ab Novel compounds II
GB0613154D0 (en) 2006-06-30 2006-08-09 Novartis Ag Organic Compounds
CA2660186A1 (en) 2006-08-07 2008-02-14 Boehringer Ingelheim International Gmbh Pharmaceutical combinations for the treatment of respiratory diseases
UY30552A1 (en) 2006-08-22 2008-03-31 Boehringer Ingelheim Int farmacologiicas combinations based on substituted derivatives n- (5- {2- [1,1-dimethyl-propylamino] -1-hydroxy-methyl} -2-hydroxyphenyl) -methanesulfonamide and applications
BRPI0719270A2 (en) 2006-10-04 2014-03-11 Pfizer Ltd Sulfonamide derivatives as muscarinic agonists and adrenergic antagonists
ES2302447B1 (en) 2006-10-20 2009-06-12 Laboratorios Almirall S.A. Derivatives of 4- (2-amino-1-hydroxyethyl) phenol as beta2 adrenergic receptor agonists.
TW200833670A (en) 2006-12-20 2008-08-16 Astrazeneca Ab Novel compounds 569
JO2754B1 (en) 2006-12-21 2014-03-15 استرازينكا ايه بي Indazolyl amide derivatives for the treatment of glucocorticoid receptor mediated disorders
SA2628B1 (en) 2007-01-11 2011-04-24 استرازينيكا ايه بي Pyridopyrimidine Derivatives as PDE4 Inhibitors
GB0702456D0 (en) 2007-02-08 2007-03-21 Astrazeneca Ab New combination
GB0702457D0 (en) 2007-02-08 2007-03-21 Astrazeneca Ab New combination 666
ES2306595B1 (en) 2007-02-09 2009-09-11 Laboratorios Almirall S.A. Napadisylate salt of 5- (2 - ((6- (2,2-difluoro-2-phenylethoxy) hexyl) amino) -1-hydroxyethyl) -8-hydroxyquinolin-2 (1H) -one as beta2 adrenergic receptor agonist .
WO2008106016A2 (en) 2007-02-27 2008-09-04 Metrosol, Inc. Prism spectrometer with moveable detector element and with collimated input light
GB0703999D0 (en) 2007-03-01 2007-04-11 Astrazeneca Ab New combination 667
ES2525716T3 (en) 2007-06-27 2014-12-29 Astrazeneca Ab Pyrazinone derivatives and their use in the treatment of lung diseases
MX2010003698A (en) * 2007-10-04 2010-04-21 Astrazeneca Ab Steroidal [3, 2-c] pyrazole compounds, with glucocorticoid activity.
MY149731A (en) 2008-02-06 2013-10-14 Astrazeneca Ab Compounds
US20110190309A1 (en) 2008-05-13 2011-08-04 Rhonan Ford PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A Beta2-ADRENOCEPTOR AGONIST
EP2300464A1 (en) 2008-05-13 2011-03-30 AstraZeneca AB Quinuclidine derivatives as muscarinic m3 receptor antagonists
UY32520A (en) 2009-04-03 2010-10-29 Astrazeneca Ab Compounds having agonist activity glucocorticoid receptor
GB0913345D0 (en) 2009-07-31 2009-09-16 Astrazeneca Ab New combination 802

Also Published As

Publication number Publication date
JP2013538867A (en) 2013-10-17
BR112013008362A2 (en) 2016-06-14
MX2013003816A (en) 2013-05-01
IL225312D0 (en) 2013-06-27
CN103249418A (en) 2013-08-14
CA2813684A1 (en) 2012-04-12
IN2013MN00567A (en) 2015-10-09
WO2012046050A1 (en) 2012-04-12
KR20130126595A (en) 2013-11-20
AU2011311310A1 (en) 2013-04-11
EP2624838A1 (en) 2013-08-14
SG188575A1 (en) 2013-04-30
RU2013115103A (en) 2014-11-20

Similar Documents

Publication Publication Date Title
EP2566479A4 (en) Azaindazoles
GB201005589D0 (en) Novel compounds
AP3107A (en) 5-Alkynyl-pyrimidines
GB201215746D0 (en) Rotocraft
HK1171452A1 (en) Substituted pyrrolidine-2-carboxamides -2-
EP2547244A4 (en) Combination juicer-blender
AP3607A (en) Substituted imidazopyridazines
TWI511851B (en) Werkstattwagen
TWI504454B (en) Bearbeitungswerkzeug
TWI452777B (en) Leiterplatten-koaxialverbinder
EP2640189A4 (en) 3-deutero-pomalidomide
HRP20181800T1 (en) Well
GB201015079D0 (en) Novel use
IL221901D0 (en) Morpholinylquinazolines
GB201007203D0 (en) Novel compounds
HK1181747A1 (en) 1-hydroxyimino-3-phenyl-propanes 1--3--
TWI462850B (en) Pedal-cleat assembly
GB201205984D0 (en) No details
GB201112400D0 (en) No details
HK1179966A1 (en) Tetrahydro-pyrido-pyrimidine derivatives --
SI2569319T1 (en) Heteroaryl-cyclohexyl-tetraazabenzošećazulenes
PT2616465E (en) Triazine-oxadiazoles
GB201012176D0 (en) Well
GB201100822D0 (en) Genrating hyrdoenergy
HK1175087A1 (en) Mammography-apparatus

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)